Participating Faculty

The American Journal of

Managed Care

This supplement to contains information on benign prostatic hyperplasia, its available treatment, and clinical and economic implications of the disease. This supplement has been peer reviewed by experts in the field.

Faculty

LaKeasha R. Batiste, MS

Xcenda

Manager

GlaxoSmithKline

Senior Director

Palm Harbor, FL

Thomas C. Fenter, MD

University of Mississippi

Blue Cross & Blue Shield of Mississippi

Vice President

Palm Harbor, FL

Muta M. Issa, MD, MBA

Emory University School of Medicine

Medical Center

Professor of Urology

Director

Baltimore, MD

Timothy S. Regan, BPharm, RPh, CPh

Xcenda

Manager, USP Health Outcomes

Research Triangle Park, NC

Manan B. Shah, PharmD, PhD

Xcenda

Faculty Disclosures

These participants report relationships with the following pharmaceutical companies:

• LaKeasha R. Batiste, MS Research support: GlaxoSmithKline

Libby Black, PharmD

Employee:

• GlaxoSmithKline
• Michael Eaddy, PharmD, PhD Research support: GlaxoSmithKline

Thomas C. Fenter, MD

Lecture support from:

• GlaxoSmithKline
• Amy L. Grogg, PharmD Research support: GlaxoSmithKline

Consultant/advisory board/honorarium:

• GlaxoSmithKline Johnson & Johnson

Consultant/advisory board, honoraria, and lecture support from:

• Boehringer-Ingelheim
• Sanofi Aventis
• Timothy S. Regan, BPharm, RPh, CPh Research support: GlaxoSmithKline

M. Chris Runken, PharmD

Employee:

• GlaxoSmithKline
• Manan B. Shah, PharmD, PhD Research support: GlaxoSmithKline

The American

Journal of Managed Care

It is the policy of to have all faculty who participate in programs sponsored by pharmaceutical companies disclose any real or apparent conflicts of interest.

GlaxoSmithKline provided funding to Xcenda to perform research and development related to this supplement. The authors listed here are employed by Xcenda, which receives grant support from GlaxoSmithKline and other pharmaceutical companies.

The American Journal of

Managed Care

Signed disclosures are on file at the office of , Princeton, New Jersey.

Funding

This supplement has been supported by funding from GlaxoSmithKline.

---

The contents of this supplement may include information regarding the use of products that may be inconsistent outside the approved labeling for these products in the United States. Physicians should note that the use of these products outside current approved labeling is considered experimental and are advised to consult prescribing information for these products.

Download PDF: Participating Faculty